165
180
1,596
533,785
ÇöÀçÁ¢¼ÓÀÚ
: 21 (ȸ¿ø 0)
Àüü±×·ì
¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬±¸¼¾ÅÍ
±è¼ºÈÆ ±³¼ö´Ô
Àüü°Ô½Ã¹°
¿ø±Û¸¸
ÄÚ¸àÆ®¸¸
ȸ¿ø¾ÆÀ̵ð :
±×·ì
°Ô½ÃÆÇ
Á¦¸ñ
À̸§
ÀϽÃ
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍÈ°µ¿ ¡¦
The 1st CPMDRC Seminar
ÃÖ°í°ü¸®ÀÚ
10-05
¾Ï¿¹¹æ¼ÒÀ硦
ÇмúÈ°µ¿
2007 The 1st CPMDRC Seminar
ÃÖ°í°ü¸®ÀÚ
10-04
¾Ï¿¹¹æ¼ÒÀ硦
°øÁö»çÇ×
Çü±¤ Çö¹Ì°æ ±³À°
ÃÖ°í°ü¸®ÀÚ
09-28
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
MRC ½ÇÇè,½Ç½À ±âÀÚÀç ±¸ÀÔ
ÃÖ°í°ü¸®ÀÚ
09-28
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ(MRC) ¾÷¹«°ü¸® ±³À° ¹×¡¦
ÃÖ°í°ü¸®ÀÚ
09-20
¾Ï¿¹¹æ¼ÒÀ硦
°øÁö»çÇ×
The 1st CPMDRC Seminar
ÃÖ°í°ü¸®ÀÚ
09-20
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅͱÔÁ¤
¿©ºñ±ÔÁ¤
ÃÖ°í°ü¸®ÀÚ
09-18
¾Ï¿¹¹æ¼ÒÀ硦
speech
2007 The 1st International Conference of¡¦
ÃÖ°í°ü¸®ÀÚ
09-11
¾Ï¿¹¹æ¼ÒÀ硦
puplished
Antiplatelet and Antithrombotic Activity¡¦
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
puplished
PKC and cofilin activation affects peri¡¦
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
Àη¾缺
´ëÇпø»ý µî·Ï±Ý Áö¿ø
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ(MRC)ÁöÁ¤ ¼ö¿©½Ä
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Antiplatelet and Antithrombotic Activity¡¦
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
°øÁö»çÇ×
´ëÇпø»ý µî·Ï ¾È³»(MRCÀåÇÐ±Ý °ü·Ã)
ÃÖ°í°ü¸®ÀÚ
08-22
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
PKCand cofilin activation affects periph¡¦
ÃÖ°í°ü¸®ÀÚ
08-01
óÀ½
ÀÌÀü
7641
7642
7643
¸Ç³¡